Literature DB >> 2440628

Effects of interferons and interleukin 2 on natural killing of cytomegalovirus-infected fibroblasts.

S Bandyopadhyay, D S Miller, M Matsumoto-Kobayashi, S C Clark, S E Starr.   

Abstract

The ability of nonadherent peripheral blood mononuclear cells of normal individuals to lyse noninfected and cytomegalovirus (CMV)-infected human fibroblasts was enhanced by preincubation with recombinant human alpha interferon (alpha-rIFN) or beta (beta-rIFN). In contrast, recombinant human gamma IFN (gamma-rIFN) augmented natural killing (NK) against both targets relatively poorly. Recombinant or natural human interleukin 2(IL-2) also augmented NK against noninfected and CMV-infected targets. Augmentation of NK by IFN or IL-2 could be blocked by the addition of corresponding antisera. IL-2-enhanced NK against CMV-infected targets was usually independent of alpha-IFN production.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2440628      PMCID: PMC1542584     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  37 in total

1.  Plaque assay of cytomegalovirus strains of human origin.

Authors:  B B Wentworth; L French
Journal:  Proc Soc Exp Biol Med       Date:  1970-11

2.  Enhancement of T cell cytotoxic responses by purified human fibroblast interferon.

Authors:  J M Zarling; J Sosman; L Eskra; E C Borden; J S Horoszewicz; W A Carter
Journal:  J Immunol       Date:  1978-11       Impact factor: 5.422

3.  Virus-specific cytotoxic lymphocyte responses are predictive of the outcome of cytomegalovirus infection of renal transplant recipients.

Authors:  A H Rook; W J Smith; J F Burdick; J F Manischewitz; W Frederick; J P Siegel; G M Williams; G V Quinnan
Journal:  Transplant Proc       Date:  1984-12       Impact factor: 1.066

4.  Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects.

Authors:  J R Ortaldo; A T Mason; J P Gerard; L E Henderson; W Farrar; R F Hopkins; R B Herberman; H Rabin
Journal:  J Immunol       Date:  1984-08       Impact factor: 5.422

5.  Effect of interferon alpha on natural killer cell cytotoxicity in kidney transplant recipients.

Authors:  A P Kelly; R T Schooley; R H Rubin; M S Hirsch
Journal:  Clin Immunol Immunopathol       Date:  1984-07

6.  Potentiation of Leu 11 + natural cytotoxicity by human interleukin 2.

Authors:  E W Ades; A Hinson; P Marder; L D Butler
Journal:  Clin Immunol Immunopathol       Date:  1984-07

7.  Deficient natural killer function in patients receiving immunosuppressive drugs: analysis at the cellular level.

Authors:  E Dupont; M Vandercruys; J Wybran
Journal:  Cell Immunol       Date:  1984-10-01       Impact factor: 4.868

8.  Augmentation of human natural cell-mediated cytotoxicity by recombinant human interleukin 2.

Authors:  L P Svedersky; H M Shepard; S A Spencer; M R Shalaby; M A Palladino
Journal:  J Immunol       Date:  1984-08       Impact factor: 5.422

9.  Long-term culture of human antigen-specific cytotoxic T-cell lines.

Authors:  S Gillis; P E Baker; F W Ruscetti; K A Smith
Journal:  J Exp Med       Date:  1978-10-01       Impact factor: 14.307

10.  Response of resting human peripheral blood natural killer cells to interleukin 2.

Authors:  G Trinchieri; M Matsumoto-Kobayashi; S C Clark; J Seehra; L London; B Perussia
Journal:  J Exp Med       Date:  1984-10-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.